Form D — SpyGlassPharma, Inc.
0001778922-25-000001 · filed Jun 5, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $74,999,989
- Reported amount sold
- $74,999,989
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SpyGlassPharma, Inc.
- CIK
- 1778922
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 27061 Aliso Creek Road
ALISO VIEJO, CA 92656 - Phone
- 949-284-6904
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick Mooney · Executive OfficerAliso Viejo, CA Find on LinkedIn ↗
-
Malik Kahook · Executive OfficerAliso Viejo, CA Find on LinkedIn ↗
-
Ali Behbahani · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Zach Scheiner · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Roger Zhang · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Cynthia Yee · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Bilal Khan · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Jake Merrill · DirectorAliso Viejo, CA Find on LinkedIn ↗
-
Geoff Pardo · DirectorAliso Viejo, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗